PHARMEXMER

Pharmexmer is a specialty pharmaceutical company headquartered in Istanbul, Turkey, dedicated to improving patient access to innovative therapies in high-need therapeutic areas. The company focuses on oncology, hematology, immunology, and rare diseases, operating through a business model that integrates the licensing of international biopharmaceutical products with the development of value-added medicines. Pharmexmer provides comprehensive services for its global partners, including regulatory affairs, market access, and full-scale commercialization within the Turkish healthcare system. By leveraging local expertise and a patient-centric approach, the company aims to bridge the gap between global medical innovation and the specific needs of the Turkish market. Their portfolio is designed to address significant unmet medical needs through both established and emerging therapeutic modalities.